Nomogram for the prediction of tigecycline-induced hypofibrinogenaemia in a Chinese population

Abstract

Tigecycline in combination with voriconazole could increase the risk of hypofibrinogenaemia, and tigecycline-induced hypofibrinogenaemia is more likely to occur in patients with malignant haematologic diseases.